English Español
Donate

Clinical Trials

A clinical trial is a research study that tries to find better ways to prevent, screen for, diagnose, or treat a disease like bladder cancer.  They are an essential part of cancer research.  Trials may provide possible treatment alternatives to patients who have not had success with standard and approved therapies.

You can search for a clinical trial below by bladder cancer disease state, state of residence and you can also look for trials nearest to you.

About Clinical Trials

✕To help find trials near you, you need to allow BCAN to access your location
Ok

Featured Trials
Title State Sponsoring Organization
CDX-585 in Patients With Advanced Malignancies New York Celldex Therapeutics
SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors Multi-State Sensei Biotherapeutics, Inc.
RO7247669 Alone or in Combination With Tiragolumab vs Atezolizumab in Participants With Untreated Locally Advanced or Metastatic Urothelial Cancer Multi-State Hoffmann-La Roche
Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer Multi-State Protara Therapeutics
Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma Multi-State VM Oncology, LLC
Bladder Cancer Screening Trial Texas University of Texas Southwestern Medical Center
Nivolumab for the Treatment of Patients With Metastatic Urothelial Cancer With ARID1A Mutation and Stratify Response Based on CXCL13 Expression Texas M.D. Anderson Cancer Center
Phase II Trial of Lurbinectedin Combined With Avelumab as Switch Maintenance Firstline Therapy Florida AdventHealth
A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer Multi-State Janssen Research & Development, LLC
Title State Sponsoring Organization
CDX-585 in Patients With Advanced Malignancies New York Celldex Therapeutics
SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors Multi-State Sensei Biotherapeutics, Inc.
RO7247669 Alone or in Combination With Tiragolumab vs Atezolizumab in Participants With Untreated Locally Advanced or Metastatic Urothelial Cancer Multi-State Hoffmann-La Roche
Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer Multi-State Protara Therapeutics
Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma Multi-State VM Oncology, LLC
Bladder Cancer Screening Trial Texas University of Texas Southwestern Medical Center
Nivolumab for the Treatment of Patients With Metastatic Urothelial Cancer With ARID1A Mutation and Stratify Response Based on CXCL13 Expression Texas M.D. Anderson Cancer Center
Phase II Trial of Lurbinectedin Combined With Avelumab as Switch Maintenance Firstline Therapy Florida AdventHealth
A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer Multi-State Janssen Research & Development, LLC

This Clinical Trials Dashboard is proudly sponsored by the Astellas/Seagen alliance, AstraZeneca, CG Oncology, Gilead, LOXO Oncology, Seagen, Tyra Biosciences and Urogen.

Learn more about the different phases clinical trials here.

Read Our Stories